Evidence map›Paper›PMID 30283678›Full record

ArticleEvolution letters2018

Evolution of bacteria specialization along an antibiotic dose gradient.

Noémie Harmand, Romain Gallet, Guillaume Martin, Thomas Lenormand

Abstract read
In one paragraph

Article in Evolution letters, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Epistasis-mediated compensatory evolution in a fitness landscape with adaptational tradeoffs.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  3. Article
  4. Microbiology (Reading, England) · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Noémie HarmandCEFE, CNRS, Univ Montpellier Univ Paul Valéry Montpellier 3, EPHE, IRD Montpellier France.
Romain GalletUMR BGPI, INRA, Montpellier SupAgro Univ. Montpellier, Cirad, TA A-54/K Montpellier Cedex 5 France.
Guillaume MartinInstitut des Sciences de l'Evolution de Montpellier UMR CNRS-UM II 5554, Université Montpellier II 34 095 Montpellier cedex 5 France.
Thomas LenormandCEFE, CNRS, Univ Montpellier Univ Paul Valéry Montpellier 3, EPHE, IRD Montpellier France.ORCID 0000-0001-8930-5393

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antibiotic and pesticide resistance of pathogens are major and pressing worldwide issues. Resistance evolution is often considered in simplified ecological contexts: treated versus nontreated environments. In contrast, antibiotic usually present important dose gradients: from ecosystems to hospitals to polluted soils, in treated patients across tissues. However, we do not know whether adaptation to low or high doses involves different phenotypic traits, and whether these traits trade-off with each other. In this study, we investigated the occurrence of such fitness trade-offs along a dose gradient by evolving experimentally resistant lines of

Indexed as

Escherichia coliexperimental evolutionfitness landscapespecialization

Identifiers

PMID30283678
PMCPMC6121860

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.